Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
20.24
-1.38 (-6.38%)
At close: May 22, 2026, 4:00 PM EDT
20.30
+0.06 (0.30%)
After-hours: May 22, 2026, 7:32 PM EDT
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $2.93 billion as of May 22, 2026. Its market cap has increased by 2,361.91% in one year.
Market Cap
2.93B
Enterprise Value
2.58B
1-Year Change
2,361.91%
Ranking
Category
Stock Price
$20.24
Market Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $2.93B, an increase of 1,773.04%. That is a compound annual growth rate of 77.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 2.93B | 145.36% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 3.22B |
| Denali Therapeutics | 2.96B |
| Relay Therapeutics | 2.95B |
| Arcus Biosciences | 2.95B |
| Dyne Therapeutics | 2.87B |
| Beam Therapeutics | 2.85B |
| Alumis | 2.81B |
| Structure Therapeutics | 2.79B |